Multidrug Resistance in Cancer: Molecular Mechanisms and Therapeutic Challenges
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 90
Special Issue Editors
Interests: cancer cell metabolism; multidrug resistance in cancer cells; Pgp activity; pH regulators in cancer; new anticancer drugs
Special Issues, Collections and Topics in MDPI journals
2. Associate Laboratory i4HB—Institute for Health and Bioeconomy, University Institute of Health Sciences—CESPU, 4585-116 Gandra, Portugal
3. UCIBIO—Applied Molecular Biosciences Unit, Translational Toxicology Research Laboratory, University Institute of Health Sciences (1H-TOXRUN, IUCS-CESPU), 4585-116 Gandra, Portugal
Interests: anticancer strategies; targeted therapy; cancer biomarkers; mitosis; apoptosis; drug discovery; bioactive compounds
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is a major cause of morbidity and mortality worldwide. Despite significant and ongoing progress in new and sophisticated therapies, treatment failure and disease recurrence remain a reality and a serious concern. Advances in identifying more specific tumor targets have led to the discovery of a host of novel compounds and innovative treatments that are more selective in identifying cancer cells and more effective at eliminating them. Nevertheless, the effectiveness of many antitumor treatments remains limited, presenting modest efficacy and resulting in the development of the MultiDrug Resistance (MDR) phenotype—a major contributor in treatment failure. The MDR defines a phenotype, either intrinsic or acquired through treatment, in which cancer cells become resistant to multiple drugs, even those with no clear structural similarity and/or that act on different molecular targets. MDR involves multiple mechanisms and molecular players, including pharmacological factors, tumor microenvironment characteristics, and intracellular mechanisms. Thus, a deeper investigation into the biological mechanisms underlying this phenotype, as well as the search for novel compounds capable not only of targeting and eliminating cancer cells but also of overcoming cellular resistance, remains critical. Despite being extensively studied, the precise role of various factors involved in MDR is far from being clarified, and new compounds able of reversing this phenotype are urgently needed.
In this Special Issue, we aim to collect review or original manuscripts covering the main mechanisms contributing to cancer resistance, including pharmacologic, microenvironment, and intracellular mechanisms. Additionally, we welcome studies focused on the development and characterization of novel and effective drugs and therapeutic strategies, either alone or in combination, that show promise in overcoming MDR and create new opportunities for cancer treatment. We therefore encourage the submission of research in this area as original research articles, review papers, or short communications.
Dr. Odília Queirós
Dr. Patrícia M. A. Silva
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer therapy
- MultiDrug Resistance (MDR)
- Pgp
- efflux pumps
- tumor microenvironment
- anticancer drug target
- combination therapy
- novel anticancer agents
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
